Leading the way in Cancer gene testing

Pathlab is pleased to announce the availability of BRAF and KRAS gene mutation testing in New Zealand. These are referred to as companion diagnostic tests and assist doctors in determining treatment options in certain cancers like melanoma. The Roche tests being used are the only CE-IVD accredited tests of their type in the world. EGFR gene mutation testing now available.  Pathlab is pleased to announce that EGFR gene mutation testing is now available in New Zealand. The EGFR test is a companion diagnostic test and assists doctors in determining treatment options in non-small cell lung cancer. The Roche test being used is the only CE-IVD accredited test of its type currently available. This new molecular oncology test is an addition to the BRAF and KRAS gene mutation testing we are already offering. 

Please click below for our Patient Fact Sheet for further information on Molecular Oncolcogy testing.

BRAF Patient Fact Sheet
EGFR Patient Fact Sheet
KRAS Patient Fact Sheet

KRAS testing is currently unavailable. For more information please contact molecular.testing@pathlab.co.nz

Please click on the PDF icons below to download the form to request a test:

 Form 1 - Request Form - Oncology Gene Testing
 Form 2 - Patient Form - Oncology Gene Testing
site maplegal information | login
evoSuite Tourism Marketing Software | Web Design by ReserveGroup
Contact Us Contact Us View our locations